{"id":2430,"date":"2016-11-01T12:06:00","date_gmt":"2016-11-01T11:06:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2016\/taenia-solium-in-nord-peru"},"modified":"2016-11-01T12:06:00","modified_gmt":"2016-11-01T11:06:00","slug":"taenia-solium-in-nord-peru","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2016\/taenia-solium-in-nord-peru","title":{"rendered":"Taenia solium in Nord-Peru"},"content":{"rendered":"<p>Die Infektion des menschlichen Gehirns mit den zystischen Larven des Schweinebandwurms (Taenia solium) ist die h\u00e4ufigste Ursache f\u00fcr die Sp\u00e4tmanifestation von Epilepsie und Krampfanf\u00e4llen weltweit (1). Bis Anfang des letzten Jahrhunderts traf das z.B. auch f\u00fcr Berlin noch zu (2). Die Transmission findet heute meist in l\u00e4ndlichen Gegenden statt, wo Menschen mit dem adulten intestinalen [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Die Infektion des menschlichen Gehirns mit den zystischen Larven des Schweinebandwurms (Taenia solium) ist die h\u00e4ufigste Ursache f\u00fcr die Sp\u00e4tmanifestation von Epilepsie und Krampfanf\u00e4llen weltweit (1). Bis Anfang des letzten Jahrhunderts traf das z.B. auch f\u00fcr Berlin noch zu (2). Die Transmission findet heute meist in l\u00e4ndlichen Gegenden statt, wo Menschen mit dem adulten intestinalen [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[4798,830,4797,4794,4795,4796],"class_list":["post-2430","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-neurozystizerkose","tag-niclosamid","tag-oxfendazol","tag-schweinebandwurm","tag-taenia-solium","tag-zystizerkose"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/2430","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=2430"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/2430\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=2430"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=2430"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=2430"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}